2010 IUPAC-Richter Prize in Medicinal Chemistry
Call for Nominations
The 2010 IUPAC-Richter Prize will be presented in August 2010 during
the EFMC International Symposium on Medicinal Chemistry in Brussels, Belgium, where the recipient will also give a plenary lecture on the subject
of his/her research. The recipient is required to repeat the lecture
at a medicinal chemistry Symposium in the USA. It is anticipated that a contribution will be made to travel expenses but this cannot
be guaranteed.
The prize is to be awarded to an internationally recognized scientist,
preferably a medicinal chemist, whose activities or published accounts
have made an outstanding contribution to the practice of medicinal chemistry
or to an outstanding example of new drug discovery.
Prize USD 10 000
The Prize has been established by a generous
gift from the Chemical Works of Gedeon Richter, Ltd. (Budapest,
Hungary) to acknowledge the key role that medicinal chemistry plays
in improving human health.
Applicants should be received by NOMINATION only, with just one person
needing to serve in that capacity, although a total of five (5) individuals
should be listed as referees overall. The package must be submitted
electronically and should contain a complete resume, a professional
autobiography of not more than two pages, and a one-page summary of
what the individual considers to be his/her activities, accomplishments
and/or publications that have had the most significant impact upon the
field of Medicinal Chemistry. The material will be forwarded confidentially
to an independent selection committee appointed by the IUPAC Subcommittee
on Medicinal Chemistry and Drug Development.
The call
for nominations for the 2010 IUPAC-Richter Prize is now open.
-deadline 31 December 2009-
For further
information, please contact Professor
C. Robin Ganellin at <[email protected]>
Nomination
materials should be submitted by 31 December 2009 to IUPAC Secretariat
by email at: [email protected]
Telephone: +1 (919) 485 8700
Fax: +1 (919) 485 8706
|
> The first prize was awarded in 2006 to Malcolm F.G. Stevens
[more]
> The second prize was awarded in 2008 to Jan Heeres [more]
> Gedeon Richter Ltd. is a major pharmaceutical company in Hungary
and one of the largest in the Central-Eastern European region. Founded
in 1901, the company has more than 100 years' experience in pharmaceutical
manufacturing. The vertically integrated firm carries out research,
development, manufacture, and marketing of human finished drugs, active
substances, and intermediates. Gedeon Richter Ltd. is a regional multinational
company in Central Eastern Europe and the CIS, and has a growing presence
through its commercial subsidiaries in key EU countries, the USA and
Japan. Two thirds of its annual sales of 599 million USD in 2004 were
exported to 80 countries (Russia, USA, EU, Japan, etc.). Production
takes place at two sites in Hungary: Budapest and Dorog. The company
also has production facilities in Poland, Russia, Romania, Ukraine,
and India. The company manufactures about 100 kinds of pharmaceuticals
in more than 170 presentations. Among its products are original, generic,
and licensed preparations. The products cover numerous therapeutic areas,
with special emphasis on the production and development of drugs for
the central nervous system, as well as antiulcer agents, cardiovascular
and gastrointestinal preparations, and oral contraceptives. Research
into drugs of the central nervous system and development of generic
products are of primary importance. Based on its traditional skills
in steroid chemistry, the company is a significant player in the gynaecological
field worldwide. <www.richter.hu>
> First Prize announcement released
online on 20 Oct 2005 and published in Chem.
Int.
Nov/Dec 2005.